Effects of the beta‐adrenergic receptor antagonist Propranolol on dyskinesia and L‐DOPA‐induced striatal DA efflux in the hemi‐parkinsonian rat

Publisher： John Wiley & Sons Inc

E-ISSN： 1471-4159|134|2|222-232

ISSN： 0022-3042

Source： JOURNAL OF NEUROCHEMISTRY (ELECTRONIC), Vol.134, Iss.2, 2015-07, pp. : 222-232

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Polymorphisms of Dopamine Receptor Genes and Risk of L-Dopa–Induced Dyskinesia in Parkinson’s Disease

By Comi Cristoforo   Ferrari Marco   Marino Franca   Magistrelli Luca   Cantello Roberto   Riboldazzi Giulio   Bianchi Maria Laura Ester   Bono Giorgio   Cosentino Marco  

International Journal of Molecular Sciences, Vol. 18, Iss. 2, 2017-01 ,pp. : 242-242

MDPI

Access to resources Recommend Favorite

The 5‐HT4 Agonist Prucalopride Stimulates L‐DOPA‐Induced Dopamine Release in Restricted Brain Regions of the Hemiparkinsonian Rat In Vivo

By  

CNS: NEUROSCIENCE AND THERAPEUTICS, Vol. 21, Iss. 9, 2015-09 ,pp. : 745-747

John Wiley & Sons Inc

Access to resources Recommend Favorite

Beta-Adrenergic Agonists

By Barisione Giovanni   Baroffio Michele   Crimi Emanuele   Brusasco Vito  

Pharmaceuticals, Vol. 3, Iss. 4, 2010-03 ,pp. : 1016-1044

MDPI

Access to resources Recommend Favorite

Receptor Subtype and Intracellular Signal Transduction Pathway Associated with Situs Inversus Induced by α1 Adrenergic Stimulation in Rat Embryos

By Fujinaga M.   Hoffman B.B.   Baden J.M.  

Developmental Biology, Vol. 162, Iss. 2, 1994-04 ,pp. : 558-567

Academic Press

Access to resources Recommend Favorite

Pioglitazone may impair L‐DOPA anti‐parkinsonian efficacy in the MPTP‐lesioned macaque: Results of a pilot study

By  

SYNAPSE (ELECTRONIC), Vol. 69, Iss. 3, 2015-03 ,pp. : 99-102

John Wiley & Sons Inc

Access to resources Recommend Favorite